MULTIPLEX PCR AND LATEX AGGLUTINATION FOR IDENTIFICATION AND CHARACTERIZATION OF TOXIGENIC CLOSTRIDIUM DIFFICILE FROM RAW MILK

Document Type : Research article

Authors

1 Department Food Hygiene, Faculty of Veterinary Medicine, Alexandria University, Egypt.

2 Department Food Hygiene, Faculty of Veterinary Medicine, Assiut University, Egypt.

Abstract

Community-acquired C.Diff. infections have recently been increasing in incidence and severity. Several studies have isolated C. Diff. spores from livestock and food suggesting that food may play a role in transmission. The overall goals of this research were to: 1) determine prevalence of C. Diff. from raw milk using selective (cycloserine-cefoxitin fructose agar [CCFA]; 2) determine toxigenic profiles of C.Diff. isolated using PCR targeting tpi and tcdB genes. A total of 50 random samples of raw marketable milk were collected from different localities in Assuit city, Egypt. The obtained results indicated that about 11 (22%) out of 50 examined raw milk samples were positive for C.Diff. using conventional method. While, 2 strains of C.Diff. (18.2%) out of the positive 11 strains could be detected using the latex agglutination test. The prevelance rate of C.Diff using multiplex PCR was one (50 %) out of the two tested strains containing the DNA of C.Diff., which  was negative for toxin B production. The public health concern of C.Diff and the suggestive measures were disscused. The prescence of toxigenic C.Diff. in raw milk is of great concern and suggests its transmission through milk, which needs proper milking and handling to reduce risk to the public health.

Keywords


MULTIPLEX PCR AND LATEX AGGLUTINATION FOR IDENTIFICATION AND CHARACTERIZATION OF TOXIGENIC CLOSTRIDIUM DIFFICILE FROM RAW MILK

 

AHLAM A. EL LEBOUDY*; NAGAH M. SAAD**; AMER, A.* and NOHA S. ELMOAZEN. *

*Department Food Hygiene, Faculty of Veterinary Medicine, Alexandria University, Egypt.

**Department Food Hygiene, Faculty of Veterinary Medicine, Assiut University, Egypt.

 

Email: bosbosadel@yahoo.com

 

 

 

ABSTRACT

 

 

Received at: 19/7/2014

 

Accepted: 19/10/2014

 

Community-acquired C.Diff. infections have recently been increasing in incidence and severity. Several studies have isolated C. Diff. spores from livestock and food suggesting that food may play a role in transmission. The overall goals of this research were to: 1) determine prevalence of C. Diff. from raw milk using selective (cycloserine-cefoxitin fructose agar [CCFA]; 2) determine toxigenic profiles of C.Diff. isolated using PCR targeting tpi and tcdB genes. A total of 50 random samples of raw marketable milk were collected from different localities in Assuit city, Egypt. The obtained results indicated that about 11 (22%) out of 50 examined raw milk samples were positive for C.Diff. using conventional method. While, 2 strains of C.Diff. (18.2%) out of the positive 11 strains could be detected using the latex agglutination test. The prevelance rate of C.Diff using multiplex PCR was one (50 %) out of the two tested strains containing the DNA of C.Diff., which  was negative for toxin B production. The public health concern of C.Diff and the suggestive measures were disscused. The prescence of toxigenic C.Diff. in raw milk is of great concern and suggests its transmission through milk, which needs proper milking and handling to reduce risk to the public health.

 

 

Keywords: Clostridium Difficile, Raw milk, latex agglutination, toxigenic, PCR.

 

 


INTRODUCTION

 

Milk is one of the few food stuffs consumed in its natural state. It is the only article in the diet, with exception of honey, whose sole function in nature is to serve as a food. It presents a favourable physical environment for the multiplication of contaminating microorganisms. One of these microorganisms, Clostridium difficile.

 

C. Diff. is a Gram positive spore forming obligatory anaerobic bacillus. Spores can persist in a wide range of aerobic environments (2, 3) was first isolated in 1935 from the stool of healthy neonates by Hall and O’Toole (2). It was only in 1978, over 40 years later, that C.Diff. was found to cause human disease in the form of diarrhea and in severe cases pseudomembranous colitis [PMC] (4, 5). C.Diff. has been associated with clinical disease in dairy calves (6,7). It has toxigenic characteristics that toxin producing strains of C.Diff. Produce two toxins –toxin A, an enterotoxin, and toxin B, a cytotoxin (8). There are four broad categories listed as sources of acquiring C. Diff. infection (CDI): environment-to-person, person-to person, animal-to-person and consumption (9).

 

Mortality rates associated with C.Diff.-related disease in the U.S. increased nearly three-fold from 1999 to 2002. A study, which included C. Diff.-related cases where C.Diff. infection was present but not listed as the underlying cause of death, demonstrated an increase in deaths from 5.7 per million population in 1999 to 23.7 per million in 2004. It is possible that the increased rates were due to the emergence of a highly virulent strains (10).

 

Owing to the incrimination of C.Diff. in PMC and littile information about it's occurrence in milk, this study aims to determine the prevelance of C.Diff. from raw milk samples by comparing cultural method by using selective medium (C.Diff. medium), latex agglutination and multiplex PCR. In addition to determination of toxigenic profile of C.Diff. isolated from raw milk using multiplex PCR.

 

MATERIALS and METHODS

 

1- Collection of samples:

A total of 50 random samples of raw marketable milk were collected from different localities in Assuit city, Egypt. Samples were transferred to the laboratory in clean, dry and sterile containers in an ice box.

 

2- Isolation of Clostridium difficile: (11)

a- Enrichment of samples:

C. Diff. broth (CDB) which is composed of proteose peptone (40.0g), disodium hydrogen phosphate (5.0g), potassium dihydrogen phosphate (1.0 g), magnesium sulphate (0.1g), sodium chloride (2.0 g), fructose (6.0g), sodium taurocholate (0.1) was used for enrichment with addition of 2 vials of Cl. difficile supplement (Oxoid, SR96), 7% defibrinated  horse blood (Oxoid SR50) and 2ml tween 80 (12). 3 gram of each sample was added to 10ml CDB with thorough mixing. Then incubated in an anaerobic cabinet (10% CO2 and 37°C) for 7 days (13).

 

b- Plating: using direct streaking method:

By streaking a 3 mm loopful to at least 3 quadrants of the plate which contains C.Diff. agar media (Oxoid CM 0601) added to it 1gm sodium taurocholate and 2ml tween 80 that improve the recovery of C. Diff. (12) and supplemented with 2 vials C.Diff. selective supplement (Oxoid SR96) and 7% defibrinated horse blood (Oxoid SR50). Supplement and horse blood added to the media at 50 ̊c not higher, which provides extra enrichment allowing for better growth (14). Plates were incubated anaerobically in 37º C for 2 days.

 

3- Identification of C.Diff.:

a- Characteristic appearance of colonies:

Typical colonies of C. Diff. appear as greyish, non hemolytic, swarming colonies (12). With typical odor of horse manure (15). Suspected colonies were subcultured on brain heart infusion agar slopes (BHI) for further identification and toxin detection.

b- Biochemical tests:

Colonies were identified by biochemical tests that they were tested for indole production and sugar fermentation which includes glucose, lactose and sucrose (16). Acid was produced with gas from glucose. Sucrose was fermented with production of acid only. lactose was not fermented by C.Diff. The pathogen didn't produce indole.

 

c- Latex Agglutination test:

The isolated strains of C.Diff. were tested for its antigen. This is an antigen antibody reaction using Oxoid agglutination kits (Oxoid DR1107A, Basingstoke, UK).

 

d- PCR ribotyping: (17)

Multiplex PCR for C.Diff. identification and toxigenic type characterization.

 

1-Primers used:

a-tpi-F(5 ̀-AAAGAAGCTACTAAGGGTACAAA-3 ̀)

tpi-R(5 ̀-CATAATATTGGGTCTATTCCTAC-3 ̀)

 

b- tcdB-F(5 ̀-GGAAAAGAGAATGGTTTTATTAA-3 ̀)

tcdB-R(5 ̀-ATCTTTAGTTATAACTTTGACATCTTT-3 ̀)

 

2- Procedure:

a- extraction of DNA by boiling and then centrifugation for 2 min. to settle bacterial debris.

b- 10 micron litre of supernatant containing DNA used for subsequent PCR amplification.

c- Thermal cycler conditions.

 

 

 

 

 

Additional comments

Initial PCR activation step:

30 sec

95°C

Hot Star Taq DNA Polymerase is activated by this heating step. Omniscript and Sensiscript Reverse Transcriptases are inactivated and the cDNA template is denatured.

3-step cycling

 

 

 

Denaturation:

0.5–1 min

94°C

 

Annealing:

30 sec

55 -65°C

Approximately 5°C below Tm of primers. Down touch procedure was implanted, annealing for 30 sec at decreasing temperature during first 11 cycles.

Extension:

30 sec

 

72°C

For RT-PCR products of 1–2 kb, increase the extension time by 30–60 s. For RT-PCR products over 2 kb.

Number of cycles:

40

 

The cycle number is dependent on the amount of template RNA and the abundance of the target transcript.

Final extension:

10 min

72°C

 

 

d- Agarose gel electrophoresis of PCR product:

Amplified reverse transcriptase–polymerase chain reaction (RT-PCR) products were analyzed by electrophoresis on 1% agarose gels and stained with ethidium bromide.

RESULTS

 

Table 1: Incidence of C.Diff. in the examined raw milk samples using conventional methods.

 

No. of examined samples

Positive samples

%

50

11

22

                          

Table 2: Frequency % of C.Diff. isolated from raw milk samples using Latex agglutination.

 

No. of examined strains

Positive strains

%

11

2

18.2

 

Table 3: Frequency % of C.Diff. isolated by using Latex agglutination from raw milk samples using Multiplex PCR.

 

No. of examined strains

positive strains

%

2

1

50

 

Table 4: Frequency % of C.Diff. toxigenic type (B) isolated by using Latex agglutination from raw milk samples using Multiplex PCR.

 

No. of examined Strains

Positive strains

%

2

0

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Photo1: Incidence of C.Diff. in the examined raw milk samples using multiplex PCR.

Lane M = Laddermarker

Lane 1= non toxigenic (B-) C.Diff strain.

Lane 2=negative C.Diff.

 


DISCUSSION

 

Table 1 showed that 11 (22%) out of 50 examined raw milk samples were positive for C.Diff. using conventional method. While, in Table 2, only 2 strains of C.Diff. (18.2%) out of the positive 11 samples could be detected using the latex agglutination test. It's clear from the obtained result that latex agglutination test is more accurate for detection of C.Diff than the biochemical reactions. Although latex agglutination test is available for the detection of C.Diff., culture of Clostridium remains essential (15).

 

Most strains of C.Diff. produce both toxin A and B which cause gastrointestinal disease with severe complications such as colonic perforation ,sepsis and death. (18,19).

 

In the current work, Table 3, cleared that only 1 strain of C.Diff. (50 %) out of the tested 2 strains containing the DNA of C.Diff. using multiplex PCR, but there was no strain positive to the C.Diff. toxigenic type B (Table 4).

 

The multiplex PCR-toxigenic culture scheme may be proposed as a reliable diagnostic method, since it provides both strain isolation and toxigenic type characterization within 36 to 48 hrs (17).

 

Previous studies have reported various prevelance rates of toxigenic C.Diff.0.2 % in the united states (20).2.5-3% in the European countries (21,22) and 6.7-9.30% in Japan (23, 24).

 

Higher results were obtained by (25) that analyzed 132 samples of raw bovine milk for toxigenic C.Diff in western Italy, the organism could be detected from 5 (3.8%) samples of bovine bulk tank milk.

 

CONCLUSION

 

The prescence of toxigenic C.Diff. in raw milk is of great concern and suggests its transmission through milk, which needs proper milking and handling to reduce risk to the public health.

 

REFERENCES

 

Barbut, F.; Lalande, V.; Burghoffer, B.; Thein, H.V. Grimprel, E. and Petit, J.C. (2002): Prevelance and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J. Clin. Microbiol. 40: 2079-2083.

BartlettJ.G.; Chang, T.W.; Gurwith, M.; Gorbach, S.L. and Onderdonk, AB. (1978): Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl. J. Med.; 298: 531-4.

Brazier, J.S.; Stubbs, S.L. and Duerden, B.I. (1999): Prevelance of toxin A negative /B positive Clostridium difficile strains. J. Hosp. Infect. 42: 248-249.

Clostridium Difficile and Wikipedia. Delme´e, M. (2001): Laboratory diagnosis of C. difficile. Microbiology Unit, Universite´ Catholique de Louvain, Brussels, Belgium. the European Society of Clinical Microbiology and Infectious Diseases, CMI, 7, n.8,  411–416.

Hafiz, S. and The Late Oakley, C.L. (1976): Clostridium Difficile: Isolation and characteristics. Department of Microbiology, MedicalSchool, University of Leeds, LS2 9NL J. Med. Microbiol.-Vol. 9.

HallI.C. and O'Toole, E. (1935): Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis Child; 49: 390-402.

Hammitt, M.C.; Bueschel, D.M.; Keel, M.K.; Glock, R.D.; Cuneo, P.; DeYoung, D.W.; Reggiardo, C.; Trinh, H.T. and Songer, JG. (2008): A possible role for Clostridium difficile in the etiology of calf enteritis. Vet Microbiol. 127(3–4): 343–352.

Issa, M.; Vijayapal, A. and Graham, M.B. (2007): “Impact of Clostridium difficile on inflammatory bowel disease,” Clinical Gastroenterology and Hepatology, vol. 5, no. 3, pp. 345–351.

Jobstl, M.; Heuberger, S.; Indra, A.; Nepf, R.; Kofer, J. and Wagner, M. (2010): Clostridium difficile in raw products of animal origin. Int. J. Food Microbial.138: 172-175.

KatoH.; Kato, N.and Watanabe, K. (1998): Identification of toxin A-negative, toxin B- positive Clostridium difficile by PCR. J. Clin Microbiol. 36: 2178-82.

Knoop, F.C.; Owens, M. and Crocker, I.C. (1993): Clostridium difficile: Clinical disease and diagnosis. Clin. Microbiol. Rev. 6: 251-265.

Komatsu, M; Kato, H.; Aihara, M.; Shimakawa, K.; Iwasaki, M.; Nagasaki, Y.; Fukuda, S.; Matsuo, S.; Arakawa, Y.; Watanabe, M. and Iwatani, Y. (2003): High frequency of antibiotic –associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur. J. Clin. Microbiol. Infect. Dis. 22: 525-529.

Larson, H.; Price, A.; Honour, P. and Borriello, S. (1978): Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 311: 1063–6.

Lemee, L.; Dhalluin, A.; Testelin, S.; Mattrat, M.A.; Maillard, K.; Lemeland, J.F. and Pons, J.L. (2004): Multiplx PCR targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Cultures of Clostridium difficile. Journal of Clinical Microbiology, Dec. P. 5710-5714.

Loo, V.G.; Bourgault, A.M. and Poirier, L. (2011): Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med; 365: 1693–1703. CrossRef, PubMed, CAS, Web of Science® Times Cited: 9.

Lyerly, D.m.; Neville, L.M.; Evans, D.T.; Fill, J.; Allen, S.; Greene, W.; Sautter, R.; Hnatuck, P.; Torpey, D.J. and Schawlbe, R. (1998): Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J. Clin. Microbiol. 36: 184-190.

Marler, L.M.; Siders, J.A.; Wolters, L.C.; Pettigrew, Y.; Skitt, B.L. and Allen, S.D. (1992): Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J. Clin. Microbiol. 30: 514-516.

Nakamura, S.; Yamakawa, K.; Izumi, J.; Nakashio, S. and Nishida, S. (1985): Germinability and heat resistance of spores of Clostridium difficile strains. Microbiol Immun 29: 113-8.

O’farreli, Sh.; Wilks, M.; Nash, J.Q. and Tabaqchali, S. (1983): A selective enrichment broth for the isolation of Clostridium difficile. Department of Medical Microbiology, St Bartholomew’s Hospital, London EC1.

Otten, A.M.; Reid-Smith, R.J.; Fazil, A. and Weese, J.S. (2010): Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect 138: 907-14.

Redelings, M.; Sorvillo, F. and Mascola, L. (2007): Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13: 1417-1419.

Rodriguez-Palacios, A.; Staempfli, H.R.; Duffield, T. and Weese, J.S. (2007): Clostridium difficile in retail ground meat, Canada emerg. infect. dis.,13: 485-487.

Romano, V. (2013): Isolation of toxigenic Clostridium difficile from raw bovine milk and the environment: arisk for public health? Intern. Congress on Bact. and Infect. Dis. Nov. 20-22.

Yaeger, M.; Funk, N. and Hoffman, L. (2002): A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus. J. Vet. Diagn Invest14(4): 281–287.

 

 

 

 

 

تفاعل البلمرة المتسلسل المتعدد واختبار التجلط للتعرف على وتمييز

الکلوستريديام ديفيسيل في اللبن الخام

 

أحلام أمين اللبودى ، نجاح محمد سعد ، عمرو عامر ، نهى المؤذن

Email: bosbosadel@yahoo.com

 

تعتبرالکلوستريديام ديفيسيل من الميکروبات اللاهوائية والتي تؤدى إلى الحالات المعوية والتي من أخطرها ثقب القولون وفى هذه الدراسة تم جمع خمسين عينة عشوائية من اللبن الخام المباع في الأسواق ، وأوضحت النتائج أن 11 عينة (22%) کانت ايجابية للکلوستريديام ديفيسيل وذلک باستخدام الطرق التقليدية. بينما کانت هناک عترتان ايجابيتان للميکروب باستخدام اختبار التجلط ، أما باستخدام اختبار البلمرة المتسلسل المتعدد أثبتت النتائج أن (50%) من العترات المختبرة کانت ايجابية والتي لم تکن بدورها مفرزة للسم B. وبذلک اثبت تفاعل البلمرة المتسلسل المتعدد انه طريقة سريعة وحساسة للکشف عن ميکروب الکلوستريديام ديفيسيل مقارنة بالطرق التقليدية. هذا وقد تم ذکر الشروط الصحية الواجب إتباعها لمنع تلوث الألبان بهذا الميکروب.

 

 

 

 

 

 

 

REFERENCES
 
Barbut, F.; Lalande, V.; Burghoffer, B.; Thein, H.V. Grimprel, E. and Petit, J.C. (2002): Prevelance and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J. Clin. Microbiol. 40: 2079-2083.
BartlettJ.G.; Chang, T.W.; Gurwith, M.; Gorbach, S.L. and Onderdonk, AB. (1978): Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl. J. Med.; 298: 531-4.
Brazier, J.S.; Stubbs, S.L. and Duerden, B.I. (1999): Prevelance of toxin A negative /B positive Clostridium difficile strains. J. Hosp. Infect. 42: 248-249.
Clostridium Difficile and Wikipedia. Delme´e, M. (2001): Laboratory diagnosis of C. difficile. Microbiology Unit, Universite´ Catholique de Louvain, Brussels, Belgium. the European Society of Clinical Microbiology and Infectious Diseases, CMI, 7, n.8,  411–416.
Hafiz, S. and The Late Oakley, C.L. (1976): Clostridium Difficile: Isolation and characteristics. Department of Microbiology, MedicalSchool, University of Leeds, LS2 9NL J. Med. Microbiol.-Vol. 9.
HallI.C. and O'Toole, E. (1935): Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis Child; 49: 390-402.
Hammitt, M.C.; Bueschel, D.M.; Keel, M.K.; Glock, R.D.; Cuneo, P.; DeYoung, D.W.; Reggiardo, C.; Trinh, H.T. and Songer, JG. (2008): A possible role for Clostridium difficile in the etiology of calf enteritis. Vet Microbiol. 127(3–4): 343–352.
Issa, M.; Vijayapal, A. and Graham, M.B. (2007): “Impact of Clostridium difficile on inflammatory bowel disease,” Clinical Gastroenterology and Hepatology, vol. 5, no. 3, pp. 345–351.
Jobstl, M.; Heuberger, S.; Indra, A.; Nepf, R.; Kofer, J. and Wagner, M. (2010): Clostridium difficile in raw products of animal origin. Int. J. Food Microbial.138: 172-175.
KatoH.; Kato, N.and Watanabe, K. (1998): Identification of toxin A-negative, toxin B- positive Clostridium difficile by PCR. J. Clin Microbiol. 36: 2178-82.
Knoop, F.C.; Owens, M. and Crocker, I.C. (1993): Clostridium difficile: Clinical disease and diagnosis. Clin. Microbiol. Rev. 6: 251-265.
Komatsu, M; Kato, H.; Aihara, M.; Shimakawa, K.; Iwasaki, M.; Nagasaki, Y.; Fukuda, S.; Matsuo, S.; Arakawa, Y.; Watanabe, M. and Iwatani, Y. (2003): High frequency of antibiotic –associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur. J. Clin. Microbiol. Infect. Dis. 22: 525-529.
Larson, H.; Price, A.; Honour, P. and Borriello, S. (1978): Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 311: 1063–6.
Lemee, L.; Dhalluin, A.; Testelin, S.; Mattrat, M.A.; Maillard, K.; Lemeland, J.F. and Pons, J.L. (2004): Multiplx PCR targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Cultures of Clostridium difficile. Journal of Clinical Microbiology, Dec. P. 5710-5714.
Loo, V.G.; Bourgault, A.M. and Poirier, L. (2011): Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med; 365: 1693–1703. CrossRef, PubMed, CAS, Web of Science® Times Cited: 9.
Lyerly, D.m.; Neville, L.M.; Evans, D.T.; Fill, J.; Allen, S.; Greene, W.; Sautter, R.; Hnatuck, P.; Torpey, D.J. and Schawlbe, R. (1998): Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J. Clin. Microbiol. 36: 184-190.
Marler, L.M.; Siders, J.A.; Wolters, L.C.; Pettigrew, Y.; Skitt, B.L. and Allen, S.D. (1992): Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J. Clin. Microbiol. 30: 514-516.
Nakamura, S.; Yamakawa, K.; Izumi, J.; Nakashio, S. and Nishida, S. (1985): Germinability and heat resistance of spores of Clostridium difficile strains. Microbiol Immun 29: 113-8.
O’farreli, Sh.; Wilks, M.; Nash, J.Q. and Tabaqchali, S. (1983): A selective enrichment broth for the isolation of Clostridium difficile. Department of Medical Microbiology, St Bartholomew’s Hospital, London EC1.
Otten, A.M.; Reid-Smith, R.J.; Fazil, A. and Weese, J.S. (2010): Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect 138: 907-14.
Redelings, M.; Sorvillo, F. and Mascola, L. (2007): Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13: 1417-1419.
Rodriguez-Palacios, A.; Staempfli, H.R.; Duffield, T. and Weese, J.S. (2007): Clostridium difficile in retail ground meat, Canada emerg. infect. dis.,13: 485-487.
Romano, V. (2013): Isolation of toxigenic Clostridium difficile from raw bovine milk and the environment: arisk for public health? Intern. Congress on Bact. and Infect. Dis. Nov. 20-22.
Yaeger, M.; Funk, N. and Hoffman, L. (2002): A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus. J. Vet. Diagn Invest14(4): 281–287.